Millennium Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-162,991
| Closed | -$51.6M | – | 6812 |
|
|
2023
Q4 | $51.6M | Buy |
162,991
+64,988
| +66% | +$12.6M | 0.02% | 769 |
|
|
2023
Q3 | $16.6M | Sell |
98,003
-56,375
| -37% | -$10.6M | 0.01% | 1594 |
|
|
2023
Q2 | $33.5M | Buy |
+154,378
| New | +$33.1M | 0.02% | 1002 |
|
|
2023
Q1 | – | Sell |
-14,660
| Closed | -$2.88M | – | 7080 |
|
|
2022
Q4 | $2.88M | Sell |
14,660
-41,127
| -74% | -$8.82M | ﹤0.01% | 3249 |
|
|
2022
Q3 | $12.5M | Buy |
55,787
+49,108
| +735% | +$9.94M | 0.01% | 1867 |
|
|
2022
Q2 | $845K | Buy |
6,679
+2,680
| +67% | +$308K | ﹤0.01% | 4529 |
|
|
2022
Q1 | $507K | Sell |
3,999
-6,767
| -63% | -$762K | ﹤0.01% | 5110 |
|
|
2021
Q4 | $1.41M | Sell |
10,766
-11,582
| -52% | -$1.5M | ﹤0.01% | 4091 |
|
|
2021
Q3 | $2.73M | Buy |
+22,348
| New | +$2.58M | ﹤0.01% | 3552 |
|
|
2021
Q2 | – | Sell |
-3,137
| Closed | -$377K | – | 7282 |
|
|
2021
Q1 | $377K | Sell |
3,137
-53,670
| -94% | -$6.08M | ﹤0.01% | 5052 |
|
|
2020
Q4 | $5.77M | Buy |
56,807
+10,935
| +24% | +$1.01M | ﹤0.01% | 2302 |
|
|
2020
Q3 | $3.55K | Buy |
45,872
+34,275
| +296% | +$2.92M | ﹤0.01% | 2131 |
|
|
2020
Q2 | $1.29M | Buy |
+11,597
| New | +$1.01M | ﹤0.01% | 2837 |
|
|
2019
Q4 | – | Sell |
-37,398
| Closed | -$610K | – | 4726 |
|
|
2019
Q3 | $610K | Sell |
37,398
-33,570
| -47% | -$652K | ﹤0.01% | 3125 |
|
|
2019
Q2 | $1.42M | Buy |
+70,968
| New | +$1.42M | ﹤0.01% | 2607 |
|
Other funds holding KRTX
Millennium Management's KRTX Position: Q1 2024 in Review
Millennium Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 162,991 shares — an estimated $51.6M sold.
Millennium Management first reported a position in KRTX in Q2 2019 and held it in 15 quarters. The position peaked at $51.6M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.
- Millennium Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Millennium Management sold 162,991 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $51.6M.
- Millennium Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 15 quarters.
- Millennium Management's Karuna Therapeutics, Inc. Common Stock position peaked at $51.6M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.